Methodological and reporting quality of breast cancer screening guidelines: a systematic review_Chinese Journal of Evidence-Based Medicine

Authors：

LI Jiang ¹ , TANG Wei ² , LI Ni ¹ , WANG Xin ³ , WANG Yong ⁴ , LV Zhangyan ¹ , FENG Xiaoshuang ¹ , WEI Luopei ¹ , LI Xin ¹ , SUN Xin ¹ ,  CHEN Wanqing ¹ ,  DAI Min ¹

1. Office of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P.R.China;
2. Department of Diagnostic Imaging, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P.R.China;
3. Department of Breast Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P.R.China;
4. Department of Ultrasonography, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P.R.China;

Corresponding?author：

CHEN Wanqing, Email: chenwq@cicams.ac.cn; DAI Min, Email: daimin2002@hotmail.com

Keywords：

Breast neoplasms screening; Guideline methodology; AGREE Ⅱ; RIGHT; Systematic review

DOI：

10.7507/1672-2531.201803081

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

ObjectivesTo systematically review the methodological and reporting quality of the current global breast cancer screening guidelines so as to provide useful information for domestic study in the future.MethodsWe searched databases including PubMed, The Cochrane Library, Web of Science, EMbase, CNKI, CBM, WanFang Data and some cancer official websites to collect breast cancer screening guidelines from inception to February, 2018. Two reviewers independently screened literature, extracted data and assessed the quality of the guidelines by using AGREE II tool and RIGHT statement.ResultsA total of 11 guidelines were included, in which 5 guidelines (45%) were issued by the USA. The results of the quality assessment showed that: the average scores in the " scale and objective”, " participants”, " rigorism”, " clarity”, " application”, and " independence” of all guidelines were 83, 48, 60, 77, 53 and 79, respectively. 6 guidelines were evaluated as level A and 5 as level B. For the reporting quality, 3 guidelines were of high quality, including 2 in the USA and 1 in Canada.ConclusionsThe methodological and reporting quality of breast cancer screening guidelines are at present very satisfactory. The quantity of clinical guidelines shows an increasing trend. Multi-country contribution to one guideline is another trend. The evidence-based methodology has been accepted globally in the guideline development.

Citation： LI Jiang, TANG Wei, LI Ni, WANG Xin, WANG Yong, LV Zhangyan, FENG Xiaoshuang, WEI Luopei, LI Xin, SUN Xin, CHEN Wanqing, DAI Min. Methodological and reporting quality of breast cancer screening guidelines: a systematic review. Chinese Journal of Evidence-Based Medicine, 2018, 18(6): 629-636. doi: 10.7507/1672-2531.201803081 Copy

1.	Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancerbase No.11. Lyon, France: International Agency for Research on Cancer, 2013. Available at: http://globocan.iarc.fr.
2.	Population division of the department of economic and social affairs of the united nations secretariat. World Population Prospects: The 2012 Revision. Available at: http://esa.un.org/unpd/wpp/Excel-Data/population.htm.
3.	陳耀龍, 楊克虎, 田金徽, 等. 循證實踐指南的制定: 國際經驗與中國實踐. 蘭州大學學報 (醫學版), 2016, 42(1): 29-35.
4.	陳耀龍, 王辰. 臨床實踐指南尋覓" 中國道路”. 健康報, 2018-02-26.
5.	Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting, and evaluation in health care. Prev Med, 2010, 51(5): 421-424.
6.	Chen Y, Yang K, Maru?ic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med, 2017, 166(2): 128-132.
7.	李楠, 姚亮, 吳瓊芳, 等. 2012-2013 年中國大陸期刊發表臨床實踐指南質量評價. 中國循證醫學雜志, 2015, 15(3): 259-263.
8.	李江, 蘇凱, 李放, 等. 肺癌篩查領域指南方法學質量的系統評價. 中國肺癌雜志, 2016, 19(10): 692-699.
9.	Ríos E, Serón P, Lanas F, et al. Evaluation of the quality of clinical practice guidelines for the management of esophageal or gastric variceal bleeding. Eur J Gastroenterol Hepatol, 2014, 26(4): 422-431.
10.	Qaseem A, Snow V, Sherif K, et al. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American college of physicians. Ann Intern Med, 2007, 146(7): 511-515.
11.	Albert US, Altland H, Duda V, et al. 2008 update of the guideline: early detection of breast cancer in Germany. J Cancer Res Clin Oncol, 2009, 135(3): 339-354.
12.	Tonelli M, Connor GS, Joffres M, et al. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ, 2011, 183(17): 1991-2001.
13.	Senkus E, Kyriakides S, Ohno S, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2015, 26 Suppl 5: v8-v30.
14.	Tozaki M, Isomoto I, Kojima Y, et al. The Japanese breast cancer society clinical practice guideline for screening and imaging diagnosis of breast cancer. Breast Cancer, 2015, 22(1): 28-36.
15.	Lauby-Secretan B, Scoccianti C, Loomis D, et al. Breast-cancer screening--viewpoint of the IARC Working Group. N Engl J Med, 2015, 372(24): 2353-2358.
16.	Siu AL, U.S. Preventive services task force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med, 2016, 164(4): 279-296.
17.	中國抗癌協會乳腺癌專業委員會. 中國抗癌協會乳腺癌診治指南與規范 (2017 版). 中國癌癥雜志, 2017, 27(9): 695-759.
18.	Bevers TB, Anderson BO, Bonaccio E, et al. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw, 2009, 7(10): 1060-1096.
19.	Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American cancer society. JAMA, 2015, 314(15): 1599-1614.
20.	ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Available at: https://www.acog.org/clinical-guidance-and-publications/practice-bulletins/committee-on-practice-bulletins-gynecology/breast-cancer-risk-assessment-and-screening-in-average-risk-women.
21.	林夏, 楊克虎, 陳耀龍, 等. 中國臨床實踐指南的現狀與思考. 中國循證醫學雜志, 2017, 17(5): 497-500.
22.	丁泓帆, 楊楠, 鄧圍, 等. WHO 指南制訂的基本原則和方法. 中國循證醫學雜志, 2016, 16(4): 471-477.
23.	Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18): E839-E842.
24.	衛茂玲, 劉鳴. 中國臨床指南循證制定的方法學現狀分析. 中國循證醫學雜志, 2013, 13(8): 927-932.
25.	王小欽, 王吉耀. 循證臨床實踐指南的制訂與實施. 北京: 人民衛生出版社, 2015.
26.	Chen Y, Wang C, Shang H, et al. Clinical practice guidelines in China. BMJ, 2018, 360: j5158.

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancerbase No.11. Lyon, France: International Agency for Research on Cancer, 2013. Available at: http://globocan.iarc.fr.
2. Population division of the department of economic and social affairs of the united nations secretariat. World Population Prospects: The 2012 Revision. Available at: http://esa.un.org/unpd/wpp/Excel-Data/population.htm.
3. 陳耀龍, 楊克虎, 田金徽, 等. 循證實踐指南的制定: 國際經驗與中國實踐. 蘭州大學學報 (醫學版), 2016, 42(1): 29-35.
4. 陳耀龍, 王辰. 臨床實踐指南尋覓" 中國道路”. 健康報, 2018-02-26.
5. Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting, and evaluation in health care. Prev Med, 2010, 51(5): 421-424.
6. Chen Y, Yang K, Maru?ic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med, 2017, 166(2): 128-132.
7. 李楠, 姚亮, 吳瓊芳, 等. 2012-2013 年中國大陸期刊發表臨床實踐指南質量評價. 中國循證醫學雜志, 2015, 15(3): 259-263.
8. 李江, 蘇凱, 李放, 等. 肺癌篩查領域指南方法學質量的系統評價. 中國肺癌雜志, 2016, 19(10): 692-699.
9. Ríos E, Serón P, Lanas F, et al. Evaluation of the quality of clinical practice guidelines for the management of esophageal or gastric variceal bleeding. Eur J Gastroenterol Hepatol, 2014, 26(4): 422-431.
10. Qaseem A, Snow V, Sherif K, et al. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American college of physicians. Ann Intern Med, 2007, 146(7): 511-515.
11. Albert US, Altland H, Duda V, et al. 2008 update of the guideline: early detection of breast cancer in Germany. J Cancer Res Clin Oncol, 2009, 135(3): 339-354.
12. Tonelli M, Connor GS, Joffres M, et al. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ, 2011, 183(17): 1991-2001.
13. Senkus E, Kyriakides S, Ohno S, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2015, 26 Suppl 5: v8-v30.
14. Tozaki M, Isomoto I, Kojima Y, et al. The Japanese breast cancer society clinical practice guideline for screening and imaging diagnosis of breast cancer. Breast Cancer, 2015, 22(1): 28-36.
15. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Breast-cancer screening--viewpoint of the IARC Working Group. N Engl J Med, 2015, 372(24): 2353-2358.
16. Siu AL, U.S. Preventive services task force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med, 2016, 164(4): 279-296.
17. 中國抗癌協會乳腺癌專業委員會. 中國抗癌協會乳腺癌診治指南與規范 (2017 版). 中國癌癥雜志, 2017, 27(9): 695-759.
18. Bevers TB, Anderson BO, Bonaccio E, et al. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw, 2009, 7(10): 1060-1096.
19. Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American cancer society. JAMA, 2015, 314(15): 1599-1614.
20. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Available at: https://www.acog.org/clinical-guidance-and-publications/practice-bulletins/committee-on-practice-bulletins-gynecology/breast-cancer-risk-assessment-and-screening-in-average-risk-women.
21. 林夏, 楊克虎, 陳耀龍, 等. 中國臨床實踐指南的現狀與思考. 中國循證醫學雜志, 2017, 17(5): 497-500.
22. 丁泓帆, 楊楠, 鄧圍, 等. WHO 指南制訂的基本原則和方法. 中國循證醫學雜志, 2016, 16(4): 471-477.
23. Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18): E839-E842.
24. 衛茂玲, 劉鳴. 中國臨床指南循證制定的方法學現狀分析. 中國循證醫學雜志, 2013, 13(8): 927-932.
25. 王小欽, 王吉耀. 循證臨床實踐指南的制訂與實施. 北京: 人民衛生出版社, 2015.
26. Chen Y, Wang C, Shang H, et al. Clinical practice guidelines in China. BMJ, 2018, 360: j5158.

Chinese Journal of Evidence-Based Medicine

Methodological and reporting quality of breast cancer screening guidelines: a systematic review

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content